Marcus & Millichap Inc Stock
€25.60
Your prediction
Pros and Cons of Marcus & Millichap Inc in the next few years
Pros
Cons
Performance of Marcus & Millichap Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Marcus & Millichap Inc | - | 4.065% | -0.775% | -11.111% | -25.146% | -31.183% | -5.185% |
Re/Max Holdings Inc | -0.760% | -0.758% | -5.072% | -9.028% | -35.149% | -71.018% | -76.439% |
Newmark Group | -1.040% | 0.526% | 0.000% | 5.525% | -21.074% | -2.051% | 61.864% |
Realogy Holdings | 2.610% | 2.614% | -4.848% | -8.187% | -0.633% | - | - |
News

IPA Capital Markets Arranges $720 Million Loan for Office-to-Residential Conversion of Former Pfizer Headquarters
IPA Capital Markets, a division of Marcus & Millichap (NYSE:MMI) specializing in capital markets services for major private and institutional clients, announced today the closing of a $720 million

Institutional Property Advisors Brokers $137 Million Luxury Multifamily Asset Sale in Suburban Phoenix
Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE:MMI) dedicated to serving the company’s institutional clients, announced today the sale of Zaterra, a 392-unit

Institutional Property Advisors Names Head of Research and Strategy
Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE:MMI) dedicated to serving the company’s institutional clients, announced today that veteran commercial real estate